Exercise Dose and Metformin for Vascular Health in Adults with Metabolic Syndrome
运动剂量和二甲双胍对代谢综合征成人血管健康的影响
基本信息
- 批准号:10357082
- 负责人:
- 金额:$ 73.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerometerAddressAdherenceAdultAerobic ExerciseAffectAttenuatedBehaviorBlood GlucoseBlood PressureBlood VesselsBody mass indexCarbohydratesCardiovascular systemCause of DeathClinicalClosure by clampDiabetes MellitusDiseaseDoseDouble-Blind MethodDouble-blind trialDrug InteractionsDrug PrescriptionsEarly treatmentEtiologyExerciseExercise TherapyFastingFunctional disorderFutureGlucoseGlucose ClampGlycosylated hemoglobin AGoalsHealthHealthcareHyperglycemiaHypertensionIndirect CalorimetryInflammationInsulinInsulin ResistanceInterventionKnowledgeMeasuresMediatingMetabolicMetabolic syndromeMetforminMicrocirculationMitochondriaMorbidity - disease rateMuscle CellsNitric OxideNon-Insulin-Dependent Diabetes MellitusOGTTObesityOutcomeOxidative StressPatientsPatternPerceptionPeripheralPharmaceutical PreparationsPharmacologyPhysical activityPhysiologic pulsePlacebosPre-Post TestsPublic HealthQuality of lifeRandomizedRecommendationResistanceRoleSignal TransductionSkeletal MuscleTestingTherapeuticTrainingTreesUltrasonographyVascular DiseasesWorkarterial stiffnessarteriolebasecardiometabolismcardiovascular healthcontrast enhanceddisorder preventiondisorder riskendothelial dysfunctionexercise adherenceexercise intensityexercise trainingglucose disposalglucose toleranceglycemic controlhealth organizationimprovedindexinginsightinsulin sensitivitymiddle agemortalityoxidationpost interventionpreventsedentary lifestyletreatment effecttrendtrial design
项目摘要
PROJECT SUMMARY/ABSTRACT
Arterial disease is the leading cause of morbidity/mortality in Metabolic syndrome (MetS). This occurs early as
evidenced by arterial dysfunction that, in turn, raises blood pressure and glucose. Health organizations
recommend exercise in an intensity based manner to promote cardiovascular adaptation and prevent disease.
Metformin is a common anti-diabetes medication that reduces future type 2 diabetes and CVD risk. However,
the optimal exercise dose to be combined with metformin for additive effects on vascular function is unknown.
Based on our preliminary work, our overall hypothesis is that metformin blunts adaptation following high
intensity exercise training (HiEx) by lowering mitochondrial derived oxidative stress signaling. We further
hypothesize that low intensity exercise (LoEx) training combined with metformin will promote additive effects
on vascular function compared to LoEx or HiEx+metformin, and maintain/improve non-exercise physical
activity patterns. In this double-blind trial, obese 30-60y MetS patients will be randomized to: 1) LoEx+placebo;
2) LoEx+metformin, 3) HiEx+placebo; or 4) HiEx+metformin for 16 weeks. We will evaluate measures of
arterial stiffness (pulse wave velocity and augmentation index), and nitric oxide-mediated arterial function in
conduit (flow mediated dilation), resistance (post-ischemic flow velocity) and microvascular (contrast enhanced
ultrasound) vessels, before and during a euglycemic clamp pre and post intervention (AIM 1). We will also
assess 24 hr blood pressure as well as determine skeletal muscle metabolic insulin resistance and glucose
tolerance (AIM 2) to address clinical and experimental questions related to health care. Further, we will
examine the effect of metformin on exercise adherence, non-exercise physical activity and quality of life during
the 16 week intervention as well as during an 8 week “free-living” period (Exploratory AIM 3) to improve public
health physical activity recommendations when co-prescribed medication. If these hypothesis are correct, they
will indicate 1) whether and how metformin should be combined with physical activity for CVD prevention, 2)
provide the first indication of whether exercise intensity reduces CVD risk via multi-level vasculature function
vs. metabolic insulin action, 3) provide a rational early treatment for people with MetS. Thus, identification of
the optimal drug to exercise interaction will illuminate how to develop individualized exercise/metformin
prescriptions to correct vascular and ameliorate metabolic insulin resistance that attenuate/prevent progression
to future diabetes and the CV morbidity and mortality.
项目总结/摘要
动脉疾病是代谢综合征(MetS)发病/死亡的主要原因。这种情况发生早,
动脉功能障碍会导致血压和血糖升高。卫生组织
建议以强度为基础的方式进行运动,以促进心血管适应和预防疾病。
二甲双胍是一种常见的抗糖尿病药物,可降低未来2型糖尿病和CVD风险。然而,在这方面,
与二甲双胍联合对血管功能产生累加效应的最佳运动剂量尚不清楚。
基于我们的初步工作,我们的总体假设是二甲双胍在高血糖后会减弱适应性,
高强度运动训练(HiEx)通过降低线粒体衍生的氧化应激信号传导。我们进一步
假设低强度运动(LoEx)训练联合二甲双胍将促进累加效应
与LoEx或HiEx+二甲双胍相比,对血管功能的影响,并维持/改善非运动体力
活动模式。在这项双盲试验中,肥胖的30- 60岁MetS患者将随机接受:1)LoEx+安慰剂;
2)LoEx+二甲双胍,3)HiEx+安慰剂;或4)HiEx+二甲双胍16周。我们将评估
动脉僵硬度(脉搏波速度和增强指数)和一氧化氮介导的动脉功能,
导管(血流介导的扩张)、阻力(缺血后血流速度)和微血管(对比增强)
超声)血管,在干预前和干预后(AIM 1)的正葡萄糖钳夹之前和期间。我们还将
评估24小时血压以及确定骨骼肌代谢胰岛素抵抗和葡萄糖
耐受性(AIM 2),以解决与医疗保健相关的临床和实验问题。此外,我们将
检查二甲双胍对运动依从性、非运动体力活动和生活质量的影响,
16周的干预以及8周的“自由生活”期间(探索性目标3),以改善公众
健康的身体活动的建议,当共同处方药。如果这些假设是正确的,
将指出1)二甲双胍是否以及如何与体力活动联合用于CVD预防,2)
提供运动强度是否经由多水平脉管系统功能降低CVD风险的第一指示
vs.代谢胰岛素作用; 3)为代谢综合征患者提供合理的早期治疗。因此,鉴定
最佳药物与运动相互作用将阐明如何开发个体化运动/二甲双胍
纠正血管和改善代谢性胰岛素抵抗的处方,
未来糖尿病和CV发病率和死亡率。
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Insulin at the Crossroads of Metabolic, Neurologic, and Vasculature Disease.
胰岛素处于代谢、神经和脉管系统疾病的十字路口。
- DOI:10.1249/jes.0000000000000187
- 发表时间:2019
- 期刊:
- 影响因子:5.7
- 作者:Malin,StevenK
- 通讯作者:Malin,StevenK
Dosing Exercise: Is More Really Better for Obesity-Related Outcomes?
- DOI:10.1002/oby.22330
- 发表时间:2018-11
- 期刊:
- 影响因子:0
- 作者:Malin SK
- 通讯作者:Malin SK
Timing Is Everything, Right? Meal Impact on Circadian Related Health.
- DOI:10.1210/clinem/dgaa533
- 发表时间:2021-01-23
- 期刊:
- 影响因子:0
- 作者:Malin SK
- 通讯作者:Malin SK
Effect of presurgical aerobic exercise on cardiometabolic health 30 days after bariatric surgery.
- DOI:10.14814/phy2.15039
- 发表时间:2021-11
- 期刊:
- 影响因子:2.5
- 作者:Gilbertson NM;Eichner NZM;Gaitán JM;Khurshid M;Rexrode EA;Kranz S;Hallowell PT;Malin SK
- 通讯作者:Malin SK
β-Aminoisobutyric Acid Relates to Favorable Glucose Metabolism through Adiponectin in Adults with Obesity Independent of Prediabetes.
- DOI:10.1155/2023/4618215
- 发表时间:2023
- 期刊:
- 影响因子:4.3
- 作者:Faiz, Habiba;Heiston, Emily M.;Malin, Steven K.
- 通讯作者:Malin, Steven K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven K Malin其他文献
Steven K Malin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven K Malin', 18)}}的其他基金
Exercise dose and metformin for vascular health in adults with metabolic syndrome
运动剂量和二甲双胍对代谢综合征成人血管健康的影响
- 批准号:
9239977 - 财政年份:2017
- 资助金额:
$ 73.23万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 73.23万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 73.23万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 73.23万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 73.23万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 73.23万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 73.23万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 73.23万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 73.23万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 73.23万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 73.23万 - 项目类别: